Increasing evidence shows that WTAP contributes to aggressive features in many tumors, including renal cell carcinoma, colorectal cancer, glioblastoma, and acute myeloid leukemia (AML) (Jin et al., 2012; Bansal et al., 2014; Zhang et al., 2016; Tang et al., 2018). This evidence concerns the gene WTAP and acute myeloid leukemia.